A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of Neuroinflammation that, for the first time, examines in depth the role of the ...
Rosh Pina, Israel, May 22, 2024 (GLOBE NEWSWIRE) -- IR-MED Inc. (IRME), (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive artificial intelligence (AI) driven spectrographic analysis ...
A phase I study of XL228, a multitargeted protein kinase inhibitor, in patients (pts) with solid tumors or multiple myeloma. Background: BMS-754807 is a potent reversible inhibitor of IGF-1R and IR ...
The study will expand to Rabin Medical Center (RMC), in parallel to Beit-Rivka, turning the study to a double center usability study. Rosh Pinna, Israel, Feb. 14, 2023 (GLOBE NEWSWIRE) -- (“IR-MED or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results